Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03313492 · ClinicalTrials.gov registry record · NA
Modifying Young Adult Skin Cancer Risk and Protective Behaviors
A NA study, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- NA
- Development phase
- 1,746
- Enrollment target
NCT03313492 is a NA study that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 1,746 participants.
The verdict
NCT03313492, a NA study, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,746 participants
- Enrollment target
Study Summary
Skin cancer is the most common cancer and can be deadly, debilitating, damaging, and disfiguring, yet is highly preventable. In 2014, the US Surgeon General made a call to action about the "major public health problem" of skin cancer, noting potential contributions of behavioral science and education, and a need for investments in such efforts. Almost five million Americans are treated for skin cancer annually, and incidence is rising. Risk factors for melanoma and non-melanoma skin cancers include personal or family history of skin cancer, certain physical characteristics (e.g., fair skin, numerous moles), as well as excessive ultraviolet (UV) radiation exposure. Our work shows that skin cancer risk behaviors, including sunburns, indoor tanning, and lack of protection peak at age 25. Thus, young adulthood is an important window for skin cancer risk reduction interventions. However, young adults tend to be resistant to public health recommendations because, as a group, they perceive themselves as having more immediate priorities than disease prevention, that the consequences of their current health behaviors are in the distant future, and they also tend to be experimenters and risk-takers highly influenced by peers. The principal investigator developed a web-based intervention (UV4.me) that was found to significantly decrease UV exposure and increase skin protection behaviors among young adults in a randomized controlled trial of nearly 1000 participants. The objective of this project is to investigate the reach, effectiveness, implementation, maintenance, and cost of an enhanced version of that web intervention (UV4.me2) in a large national randomized controlled trial. The ultimate goal is to improve the skin cancer protection behaviors (and potentially decrease skin cancer incidence) among a national sample of young adults at moderate to high risk of developing skin cancer. Primary Aim 1. To enhance and determine intervention reach (i.e., enrollment, representa
Interventions
- BEHAVIORAL UV4.me2
- BEHAVIORAL UV4.me
- BEHAVIORAL E-Pamphlet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,746 participants |
| Start Date | 2018-09-07 |
| Est. Completion | 2020-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03313492
The ClinicalTrials.gov registry entry for NCT03313492 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,746 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which UV4.me2 is the first listed.
NCT03313492 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03313492 about?
NCT03313492 is a clinical study titled "Modifying Young Adult Skin Cancer Risk and Protective Behaviors". Skin cancer is the most common cancer and can be deadly, debilitating, damaging, and disfiguring, yet is highly preventable. In 2014, the US Surgeon General made a call to action about the "major public health problem" of skin cancer, noting potential contributions of behavioral science and educatio...
What is the current status of trial NCT03313492?
This trial is currently completed. It is a NA study. The enrollment target is 1,746 participants. The study started on 2018-09-07. Estimated completion is 2020-07-31.
What interventions are being tested in trial NCT03313492?
The interventions under investigation include: UV4.me2 (BEHAVIORAL), UV4.me (BEHAVIORAL), E-Pamphlet (BEHAVIORAL).
Who is sponsoring clinical trial NCT03313492?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.